X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/12/15/2796782/0/en/Neoleukin-Therapeutics-Announces-1-for-4-Reverse-Stock-Split.html
https://www.globenewswire.com//news-release/2023/09/22/2747927/0/en/Neoleukin-Therapeutics-Announces-1-for-5-Reverse-Stock-Split.html
https://www.fiercebiotech.com/biotech/neurogene-inks-neoleukin-reverse-merger-raises-95m-fund-gene-therapies-clinical-data-drops
https://endpts.com/neoleukin-sends-70-of-staff-packing-as-il-2-biotech-searches-for-sale-or-other-exit/
https://www.globenewswire.com//news-release/2022/12/12/2572217/0/en/Neoleukin-Therapeutics-Presents-Preclinical-Data-on-NEO-TRA1-at-American-Society-of-Hematology-ASH-Annual-Meeting.html
https://www.fiercebiotech.com/biotech/adamis-harpoon-neoleukin-and-tricida-add-biotech-layoff-wave-pipeline-setbacks-spur-cuts
https://www.globenewswire.com/news-release/2022/11/14/2555436/0/en/Neoleukin-Therapeutics-Announces-Third-Quarter-2022-Financial-Results-and-Corporate-Update.html
https://www.globenewswire.com/news-release/2022/11/03/2547817/0/en/Neoleukin-Therapeutics-Announces-Oral-Presentation-at-64th-American-Society-of-Hematology-ASH-Annual-Meeting.html
https://www.globenewswire.com/news-release/2022/08/09/2495267/0/en/Neoleukin-Therapeutics-Announces-Second-Quarter-2022-Financial-Results-Provides-Corporate-Update.html
Market Place
Share 
